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https://doi.org/10.101Mesenchymal stromal cells (MSCs) support hematopoietic stem cells (HSCs) in vivo
and enhance HSC engraftment and hematopoietic recovery upon cotransplantation
with HSCs. These data have led to the hypothesis that MSCs may affect the HSC niche,
leading to changes in HSC retention and trafficking. We studied the effect of MSC
administration on the HSC compartment in the bone marrow (BM) in mice. After
injection of MSCs, HSC numbers in the BM were decreased coinciding with an
increased cell cycle activity compared with phosphate-buffered saline (PBS)-injected
controls. Furthermore, the frequency of macrophages was significantly reduced and
niche factors including Cxcl12, Scf, and Vcam were downregulated in endosteal cells.
These BM changes are reminiscent of events associated with granulocyte colony-stimu-
lating factor (G-CSF)-induced hematopoietic stem and progenitor cell (HSPC) mobili-
zation. Interestingly, coadministration of MSCs and G-CSF resulted in a twofold
increase in peripheral blood HSPC release compared with injection of G-CSF alone,
whereas injection of MSCs alone did not induce HSPC mobilization. After intravenous
administration, MSCs were only observed in the lungs, suggesting that they exert their
effect on the HSC niche through a soluble mediator. Therefore, we tested the hypothe-
sis that MSC-derived extracellular vesicles (EVs) are responsible for the observed
changes in the HSC niche. Indeed, administration of EVs resulted in downregulation of
Cxcl12, Scf, and Vcam and enhanced G-CSF-induced HSPC mobilization at similar lev-
els as MSCs and G-CSF. Together, these data indicate that MSCs induce a permissive
state in the BM, enhancing HSPC mobilization through the release of EVs. © 2018








108TaggedPHematopoietic stem cells (HSCs) replenish the periph-
eral blood (PB) cell pool throughout life. During
homeostasis, the vast majority of HSCs reside in spe-
cialized niches located in the perivascular area of the
trabeculated region of the bone marrow (BM). This
HSC microenvironment regulates self-renewal, cell
cycle entry, and differentiation of HSCs and consists: M. van Pel, Ph.D., Department of Immunohematol-
fusion, Leiden University Medical Center, P.O. Box
, The Netherlands; E-mail: m.van_pel@lumc.nl










EH – Society for Hematology and Stem Cells. Published
6/j.exphem.2018.05.002TaggedPof a complex network of hematopoietic and nonhema-
topoietic cells (see previous reviews [1,2]).
TaggedPIn the BM, the majority of HSCs are found in close
proximity to mesenchymal stromal cells (MSCs) sur-
rounding arterioles and sinusoids [36]. MSC-derived
CXCL12 and stem cell factor (SCF) are indispensable
for HSC maintenance because deletion of either
CXCL12 or SCF leads to hematopoietic exhaustion
[711]. HSCs are retained in the niche by adhesion
molecules, including b1-integrins, interacting with
extracellular matrix components and with vascular cell
adhesion molecule (VCAM), which is expressed on
stromal cells [12].
TaggedP he endosteal region of the BM contains a popula-
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230TaggedPosteomacs) supporting osteoblast differentiation and
mineralization and contributing to the maintenance of
HSC niches [13]. Another BM-resident macrophage
population, expressing CD169, supports the retention
of HSCs by acting on stromal cells in the niche [15].
Depletion of osteomacs or CD169+ macrophages results
in downregulation of Cxcl12, Vcam, Ang-1, and Scf and
results in subsequent hematopoietic stem and progeni-
tor cell (HSPC) mobilization [1315].
TaggedP hrough administration of exogenous cytokines,
HSPCs can be induced to leave the niche and migrate
toward the PB in a process called mobilization. Granu-
locyte-colony stimulating factor (G-CSF) is most com-
monly applied as a mobilizing agent.
TaggedP he administration of G-CSF is accompanied by
neutrophil expansion and a proteolytic BM milieu coin-
ciding with decreased levels of the protease inhibitor
alpha-1-antitrypsin (AAT) [16,17]. Simultaneously with
neutrophil expansion, G-CSF administration leads to
depletion of macrophages, resulting in decreased
expression of Cxcl12, Vcam, and Scf by BM stromal
cells and in decreased osteoblast numbers [14,15].
Together, these events result in decreased adhesion of
HSPCs to their niche and, as a consequence, HSPCs
migrate toward the PB.
TaggedPMSCs are a nonhematopoietic population of cells
that form fibroblast colony-forming units and have the
capacity to differentiate into osteoblasts, adipocytes,
and chondrocytes. MSCs can be isolated from the BM,
where they are an essential part of the HSC niche [2].
When cotransplanted with CD34+ umbilical cord
blood-derived HSPCs, MSCs enhance both HSC
engraftment and hematopoietic recovery [18,19].
Although the underlying mechanisms are not fully
understood, it was suggested that HSC homeostasis is
altered indirectly through factors released by the
injected MSCs because intravenously injected MSCs
could not be detected in the BM after administration
[19].
TaggedPGiven the key role of MSCs in the HSC microenvi-
ronment and their effect on HSC engraftment and
hematopoietic recovery, we have investigated the effect
of MSC administration on the hematopoietic BM com-
partment. Here, we show that intravenous administra-
tion of MSCs results in changes in the BM that are
reminiscent of events that occur during G-CSF-induced
HSPC mobilization. Furthermore, coinjection of MSCs
and G-CSF synergistically enhanced HSPC mobiliza-
tion compared with G-CSF alone. MSCs retained in the
lung exerted their effects on the BM through the secre-
tion of extracellular vesicles (EVs). Administration of
EVs alone resulted in downregulation of Cxcl12, Scf,
and Vcam and enhanced G-CSF-induced HSPC mobili-
zation at similar levels as MSCs. Together, these data




TaggedPEight- to 12-week-old male C57BL/6-Ly5.2 and C57BL/6-
Ly5.1 mice were obtained from Charles River Laboratories
(Maastricht, The Netherlands). The animals were fed com-
mercial rodent chow and acidified water ad libitum and were
maintained in the animal facility of the Leiden University
Medical Center (LUMC) under conventional conditions. All
experimental protocols were approved by the institutional
ethics committee on animal experiments.
Mesenchymal stromal cells
TaggedPMSCs were obtained by culturing bone chips in a 75 cm2
flask in MSC medium containing a-minimum essential
medium (Life Technologies), 10% fetal calf serum (FCS),
penicillin/streptomycin, and L-glutamine. Plastic adherent
MSCs were cultured to 95% confluency in a fully humidified
atmosphere at 37˚C and 5% CO2, harvested using trypsin,
and further expanded until sufficient numbers were obtained.
MSCs used throughout this study were of passage six to ten.
MSCs were administered intravenously in 0.1% bovine serum
albumin/PBS (0.1% BSA/PBS) at a dose of 200£ 103 cells
per day for 3 consecutive days. Mice injected with 0.1%
BSA/PBS served as controls. In indicated experiments, MSCs
were cultured in the presence of recombinant murine inter-
feron-gamma (IFN-g) (20 ng/mL) or recombinant murine
tumor necrosis factor-alpha (TNF-a) (20 ng/mL; both R&D
Systems, Abingdon, UK) for 7 days. Where indicated, MSCs
were transduced with a lentiviral vector containing SFFV-
DsRed-Firefly luciferase (SFFV-DsR-Fluc) as described pre-
viously [21]. Images were acquired and analyzed as
described previously [21]. To obtain MSC culture superna-
tant, MSCs at a confluency of 7080% were cultured for 1
week in StemSpan (STEMCELL Technologies, K€oln, Ger-
many). Subsequently, the medium was harvested, centrifuged
to deplete for cell debris, and concentrated using Centriprep
YM3 filters (Millipore, Amsterdam, the Netherlands) to
obtain an »20-fold concentration. In indicated experiments,
200 mL of MSC culture supernatant was administered intra-
peritoneally twice daily for 3 consecutive days.
Cell lines
TaggedPRAW264.7 cells (gift from A. van Wengen, LUMC) were
cultured in RPMI-1640 medium containing 10% FCS, peni-
cillin, streptomycin and L-glutamine. S17 and MS-5 cells
(gift from F.J.T. Staal, LUMC) were cultured in MSC
medium and MSC medium with 50 mmol/L 2-mercaptoetha-
nol (Sigma-Aldrich, Zwijndrecht, The Netherlands), respec-
tively.
TaggedPIn coculture experiments, 35£ 103 stromal cells were cul-
tured in their respective medium for 16 hours and then
medium was removed and RAW264.7 cells were added in a
1:1 ratio and cultured for 72 hours in MSC medium.
RAW264.7 cells were either added directly to the stromal





























































E.-J.F.M. de Kruijf et al. / Experimental Hematology 2018;00:00-00 3TaggedP(Corning Costar). Stromal cells were harvested using Accu-
max (eBioscience). RAW264.7 cells were depleted using




















309Preparation of cell suspensions and BM extracellular
extracts
TaggedP wenty-two to 24 hours after the last MSC administration,
mice were sacrificed by CO2 asphyxiation. PB was obtained
by intracardiac puncture and cell counts were performed on a
Sysmex XP-300 counter (Sysmex, Etten-Leur, The Nether-
lands). PB was centrifuged at 350 g and blood plasma was
stored at 20˚C. Erythrocytes were lysed using a specific
lysis buffer (LUMC Pharmacy, Leiden, The Netherlands)
before further analysis. BM and spleen cells were harvested
as described previously [22].
TaggedPBM extracellular extracts were obtained by flushing
femurs with 250 mL of cold PBS. The cell suspension was
centrifuged at 350 g for 7 minutes at 4˚C. The supernatant
was stored at 20˚C.
TaggedP o enumerate osteoclasts, 1£ 105 BM cells were seeded
in quintuplicate in a 96-well flat-bottomed plate and stained
using the tartrate-resistant acid phosphatase (TRAP) staining







315Antibodies for cell analysis
TaggedPAll antibodies used are described in Table 1. Cells were ana-
lyzed on a FACSCanto II flow cytometer with Diva software

























Isotype for Ki67 PE-Cy7
Streptavidin Pacific Orange5-Fluorouracil
TaggedP5-Fluorouracil (5-FU, F6627, Sigma-Aldrich) was dissolved
in PBS and administered at a concentration of 150 mg/kg
intraperitoneally. Cell recovery was determined every
23 days, but individual mice were only bled weekly to
avoid excessive stress. A small volume of blood was drawn
from the tail vein. Cell counts were performed on a Sysmex
XP-300 counter. After lysis of erythrocytes, cells were
stained with CD11b-, Ly6G-, BB20-, CD3-, and Ly6C-spe-
cific antibodies (Table 1).
Quantitative real-time polymerase chain reaction
TaggedPAfter obtaining BM cells by flushing the femurs, the same
femurs were flushed with PBS and RLT buffer (Qiagen) to
obtain cell lysates of endosteal cells. RNA was obtained
using the RNeasy mini kit (Qiagen) according to the man-
ufacturer’s recommendations and cDNA was generated using
Superscript III (Invitrogen). Primer sets used for quantitative
real-time polymerase chain reaction (qRT-PCR) experiments
are shown in Table 2. qRT-PCR was performed using Taq-
Man Universal MasterMix (Thermo Fisher) and Universal
Probes (Roche) on a StepOnePlus cycler (Thermo Fisher).
Relative gene expression was calculated using the compara-
tive threshold cycle (CT) method, with Hprt, Abl, or Gapdh
as the endogenous reference genes.
Administration of recombinant human G-CSF
TaggedPMice were injected intraperitoneally with 10 mg of recombi-
nant human G-CSF (Amgen, Thousand Oaks, California,
USA) in 0.2 mL of 0.1 % BSA/PBS once a day for 3





















































Table 2. Overview of the primer pairs used in the study

























































































4 E.-J.F.M. de Kruijf et al. / Experimental Hematology 2018;00:00-00Progenitor cell assays
TaggedP wo hundred microliters of PB was depleted of erythrocytes
using a specific lysis buffer (LUMC Pharmacy). Next, the
equivalent of 100 mL of PB was cultured in duplo X X in 3.5 cm
dishes containing semisolid medium supplemented with
recombinant murine GM-CSF (1.25 ng/mL; BD Biosciences),
recombinant murine interleukin-3 (IL-3) (25 ng/mL; BD-Bio-
sciences), recombinant human erythropoietin (0.2 units/mL;
LUMC Pharmacy), and recombinant human G-CSF (100 ng/mL;
Amgen). After 6 days of culture, the number of colonies (defined









TaggedPRecipients were irradiated in Perspex chambers using an
Orthovolt (Xstrahl Medical, Walsall, UK). A total dose of
9.5 Gy total body irradiation (TBI) was administered. Four
hours after TBI, 750£ 103 PB mononuclear cells were










TaggedPRecombinant murine osteoprotegerin (OPG) was obtained
from R&D Systems (Minneapolis, USA), dissolved in PBS,
and administered intravenously before G-CSF administration.
The OPG concentration was determined using a mouse OPG
immunoassay (R&D Systems) according to the man-
ufacturer’s recommendations. M-CSF concentrations were
















TaggedPEV-depleted MSC medium was obtained by centrifuging
MSC medium at 100,000 g at 4˚C for 16 hours using a Beck-
man Coulter Ultracentrifuge. MSCs were cultured for
72 hours in EV-depleted medium. Culture supernatant was
sequentially centrifuged at 350 g for 10 minutes and at
10,000 g for 30 minutes to discard cell debris. Supernatant
was collected and centrifuged for 70 minutes at 100,000 g.
The pellet containing EVs was washed in PBS for 70 minutes
at 100,000 g and resuspended in PBS. EVs were quantified
using a qNano particle analyzer (Izon Science, Oxford, UK).
EV preparations had a mean particle diameter of 133.7 §
3.2 nm. Typically, 5.3£ 1010 § 1.7£ 1010 EVs were isolated
per 1£ 106 MSCs after 3 days of culture. Where indicated,
EVs were stained in diluent C solution for 10 minutes using
a PKH26 kit (Sigma-Aldrich). Staining was stopped byTaggedP dding 1% BSA/PBS. Next, EVs were washed for 70 minutes
at 100,000 g and resuspended in PBS.
Statistical analysis
TaggedPAll values are presented as mean with standard error of the
mean. All groups were compared using the unpaired t test
with Welch’s correction when applicable. All statistical cal-
culations were performed using GraphPad Prism software (La
Jolla, California, USA). p  0.05 was considered statistically
significant.
Results
MSC administration increases HSPC cycle activity
TaggedP o investigate the effect of MSC administration on the
hematopoietic compartment in the BM, cohorts of C57BL/
6 mice received three consecutive daily injections of
MSCs. On day 4, mice were sacrificed and BM cells were
analyzed. The absolute number of HSCs (defined as
LinSca-1+c-KitHI [LSK] CD34CD135) was signifi-
cantly decreased (Figure 1D), whereas the total number of
white blood cells (WBCs) per femur and the colony-form-
ing capacity of the BM remained comparable to controls
(Figures 1A and 1B). Moreover, there was a trend toward
decreased numbers of LSK cells, hematopoietic progenitor
cells (HPCs), X X and MPPs per femur (Figures 1C1F). To
investigate whether the decrease in HSC numbers was due
to altered cell cycle activity of HSPCs, the cell cycle sta-
tus of the hematopoietic cells after MSC administration
was assessed. The frequency of LSK cells in the G1 phase
of cell cycle was a 3.2-fold increase compared with PBS-
treated controls, whereas the frequencies of LSK cells in
the G0 and the S/G2/M phase were decreased with 64%
and 50.7% of PBS controls (Figure 1G). A similar shift in
cell cycle activity was observed for HSCs and HPCs/
MPPs (Supplementary Figures E1A and E1B, online only,
available at www.exphem.org). The cytoreductive agent 5-
FU kills actively cycling cells, including cycling HSPCs,
and induces a BM stress response. In the PB, WBCs were
decreased within days after 5-FU injection (Figures 1H
and 1I). Administration of MSCs for 3 consecutive days
followed by 5-FU injection delayed WBC recovery com-
pared with controls receiving PBS and 5-FU. This delay



































































































































































Days after 5-FU administration
* *
*
Figure 1. MSC administration increases HSPC cell cycle activity. After 3 days of intravenous MSC or PBS administration, femurs were isolated
and analyzed for (A) total WBC numbers and (B) the number of colony-forming cells (CFU-C); n = 68 per group. (CF) The absolute number
of LSKs, HSCs, HPCs, and MPPs per femur was determined by fluorescence-activated cell sorting analysis; n = 6 per group. (G) Cell cycle activ-
ity of LSK cells was analyzed using a Ki67/DAPI staining. The frequencies of LSK cells in G0, G1, or S/G2/M phase was determined using flow
cytometry. (H,I) After 3 daily intravenous injections of MSCs, mice received 5-FU at a dose of 150 mg/kg (day 0); WBCs per milliliter of PB
(H) and the absolute number of granulocytes per milliliter of PB (I) were determined at weekly intervals after 5-FU administration (n = 5 per
group). Data are depicted as mean § standard error of the mean of two separate experiments. *p < 0.05, **p < 0.01, ***p < 0.001 all com-
pared with PBS.
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560TaggedPcompartment (Figures 1H and 1I). Together, these results
indicate that administration of MSCs leads to a reduction
of the number of LSK cells in the BM and induces HSPCs
into the cell cycle.
MSCs downregulate niche factors in the BM
TaggedP he HSC niche regulates HSC cell cycle entry. There-
fore, the observed increase in cell cycle activity of
HSPCs after MSC administration may be explained by
changes in the niche. Macrophages have been shown to
contribute to anchoring HSCs in the niche and their
depletion leads to downregulation of HSC retention
factors including CXCL12 and VCAM in stromal cellsTaggedP nd their depletion induced HSPC mobilization
[14,15]. In turn, MSCs act on cells of the innate
immune system, including macrophages [2325]. For
these reasons, we hypothesized that MSCs may alter
the HSC niche through macrophages as intermediate
cells. Therefore, the presence of osteomacs and
CD169+ macrophages was assessed in BM after MSC
administration. A significant decrease in osteomacs and
CD169+ macrophages was observed compared with
PBS-injected controls (Figures 2A2F). Moreover,
osteoclasts, which are macrophages specialized in regu-
lating bone metabolism, were also decreased (p = 0.057;




























































































































































































































































Figure 2. MSC administration induces downregulation of niche factors in the BM. (AC) Osteomacs (n = 12), (DF) CD169+ macrophages
(n = 6), and (G) osteoclasts (n = 1013) were analyzed on day 4 after 3 consecutive days of PBS or MSC administration. Relative RNA expres-
sion for (H) Cxcl12, (I) Vcam, and (J) Scf was determined in bone-lining cells after PBS or MSC administration and are depicted as the relative
expression compared with the household gene HPRT (n = 1115 from five separate experiments). (KM) Stromal cells downregulate (K)
Cxcl12, (L) Vcam, and (M) Scf upon cellcell contact with RAW264.7 macrophages. RAW264.7 cells are cocultured with S17 or MS-5 stromal
cells either in a Transwell (TW) or in direct cellcell contact (Well; n = 411 from two to five separate experiments). Data are depicted as
mean § standard error of the mean. *p < 0.05, **p < 0.005, ***p < 0.0005 all compared with PBS.
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Figure 3. MSCs enhance G-CSF-induced HSPC mobilization through a soluble factor. (A) MSCs (M) were administered intravenously for
3 days at a dose of 200£ 103 cells per day to recipients that were simultaneously mobilized with G-CSF (G) (10 mg per day intraperitoneally
for 3 days) or PBS (P) as a control (n = 1630 per group). (B) The absolute number of LSK cells in the PB was analyzed using flow cytometry
(n = 811 per group). (C) Equal numbers of PB cells obtained from G-CSF- or MSC + G-CSF-mobilized donors were transplanted into lethally
irradiated recipients and donor chimerism for (C) total leukocytes and (D) granulocytes was assessed (n = 10 per group). (E) IFN-g- and TNF-
a-stimulated MSCs enhance G-CSF mobilization at levels similar to unstimulated MSCs. (F) MSC administration before G-CSF-induced mobili-
zation enhances HSPC mobilization significantly. MSCs were administered intravenously for 3 days at a dose of 200£ 103 cells per day to recip-
ients, followed by G-CSF administration on subsequent days (10 mg per day intraperitoneally for 2 or 3 days) or PBS as a control (n = 36 from
two independent experiments). (GI) Relative RNA expression for (G) Cxcl12, (H) Vcam, and (I) Scf was determined in bone-lining cells after
G-CSF or MSC + G-CSF administration and depicted as relative expression compared with the household gene HPRT (n = 1014 from five
ARTICLE IN PRESS

























































































































































































































885TaggedP dministration coincided with increased levels of the
osteoclast inhibitor OPG in the BM extracellular fluid
(p = 0.07), whereas the levels of M-CSF remained
unchanged (Supplementary Figures E2A and E2C,
online only, available at www.exphem.org).
TaggedPIt has been reported that depletion of BM macro-
phages in vivo results in downregulation of Cxcl12,
Vcam, Ang-1, and Scf [1315]. Similarly, after MSC
administration, the expression of Cxcl12 and Vcam was
decreased significantly in endosteal cells, whereas a
modest decrease in Scf expression was observed
(Figures 2H2J).
TaggedP o further study the effect of macrophages on gene
expression in stromal cells, in vitro culture experiments
were performed in which cells of the immortalized
macrophage cell line RAW264.7 were incubated with
either S17 or MS-5 stromal cells. Cultures were per-
formed in a Transwell setting to investigate the effect
of secreted factors or cellcell contact. Next, gene
expression was assessed. Direct cellcell contact
between RAW264.7 and stromal cells downregulated
the expression of Cxcl12, Vcam and Scf significantly
compared with S17 and MS-5 cultured in the absence
of RAW264.7 cells. Factors secreted by RAW264.7
cells that were cultured in a Transwell only mildly
affected the expression of Cxcl12, Vcam, and Scf
(Figures 2K2M).
TaggedPNot only macrophages, but also B lymphocytes,
were decreased significantly in the BM and PB after
MSC administration (Supplementary Figures
E2DE2F, online only, available at www.exphem.org).
This decrease coincided with a significant reduction in
IL-7 expression in endosteal cells. Given the crucial
role of IL-7 in B lymphopoiesis [26], these results sug-
gest that MSC administration may impair B lympho-
poiesis in the BM.
MSCs enhance G-CSF-induced HSPC mobilization
TaggedP he depletion of macrophages and the downregulation
of Cxcl12, Vcam, and Scf observed after MSC adminis-
tration have been reported to also occur during G-CSF-
induced HSPC mobilization [14,27]. Therefore, we
hypothesized that MSC administration may affect G-
CSF-induced HSPC mobilization. To investigate this,
MSCs were administered for 3 days to mice that were
simultaneously mobilized with G-CSF. MSCs and G-
CSF co-injection induced a twofold increase in HSPC
mobilization compared with G-CSF administration
alone, whereas administration of MSCs alone did not
induce HSPC migration (Figure 3A). This effect wasseparate experiments). (J) MSCs are trapped in the lung vasculature upon
administered for 3 days. At day 4, MSCs were visualized by administration
administration of G-CSF and serum-free culture supernatant (S) enhanc
depicted as means § standard error of the mean. *p < 0.05, **p < 0.01, **TaggedPspecific for MSCs because co-injection of splenocytes
and G-CSF did not enhance HSPC mobilization
(Supplementary Figure E3A, online only, available at
www.exphem.org). A modest increase in LSK cells
was observed in the PB (Figure 3B). To investigate
whether MSCs and G-CSF coadministration increased
the number of long-term repopulating HSCs in the PB,
equal numbers of PB cells obtained after coinjection of
MSCs and G-CSF or after G-CSF administration alone
were transplanted into lethally irradiated recipient
mice. Recipients of PB obtained from MSC- and G-
CSF-mobilized donors showed significantly higher lev-
els of donor leukocytes and granulocytes up to 19
weeks after transplantation compared with recipients of
G-CSF-mobilized PB (Figures 3C and 3D). This indi-
cates that co-administration of MSCs and G-CSF
enhanced the mobilization of HSCs with long-term
repopulating ability compared with G-CSF alone.
TaggedPIt has been shown previously that the immunomodu-
latory capacity of MSCs is enhanced in an inflamma-
tory environment [25]. To determine whether exposure
to inflammatory cytokines further enhances the capac-
ity of MSCs to increase G-CSF-induced HSPC mobili-
zation, MSCs were stimulated with IFN-g and TNF-a
before co-administration with G-CSF. IFN-g- and
TNF-a-stimulated MSCs indeed enhanced G-CSF
mobilization, but cytokine-stimulated MSCs did not
further enhance this effect compared with unstimulated
MSCs (Figure 3E).
TaggedP he effect that MSCs exert on the HSC niche seems to
be independent of the effect established by G-CSF
because administration of MSCs 3 days before G-CSF
administration induced the same enhancement of G-CSF-
induced mobilization as simultaneous MSCs and G-CSF
administration (Figure 3F). In addition, administration of
MSCs does not increase the levels of neutrophil elastase
in the BM (p = 0.28; Supplementary Figure E3B, online
only, available at www.exphem.org). A direct effect of G-
CSF on MSCs can be excluded because MSCs do not
express the G-CSF receptor (Supplementary Figure E3C,
online only, available at www.exphem.org). Because
osteoclasts were decreased upon MSC administration in
combination with an increase in OPG (Figure 2G and
Supplementary Figure E2A, online only, available at
www.exphem.org), we assessed whether administration of
OPG would enhance G-CSF-induced HSPC mobilization.
However, no effect of OPG on G-CSF-induced mobiliza-
tion was observed (Supplementary Figure E2B, online
only, available at www.exphem.org). To investigate the
effect of MSC and G-CSF co-administration on nicheintravenous administration. Firefly luciferase-transduced MSCs were
of luciferin followed by bioluminescence imaging. (K) Simultaneous






















































































































1000TaggedP enes, the expression of Cxcl12, Vcam, and Scf was
assessed in endosteal cells. As expected, the expression
of these genes was decreased after G-CSF administra-
tion. Moreover, co-administration of MSCs and G-CSF
further downregulated the expression of these genes
(Figures 3G3I).
MSCs enhance G-CSF-induced mobilization through a
soluble factor
TaggedP o investigate the fate of MSCs upon intravenous
administration, MSCs transduced with a lentiviral con-
struct containing SFFV-DsR-Fluc were administered
for 3 days and visualized by luciferin. Upon intrave-
nous administration, MSCs migrated toward the lungs.
No MSC migration to other locations was observed.
This may be due to the sensitivity of the technique
because a minimum of 5000 MSCs is required to
obtain a signal that is distinguishable from background
[21]. However, these results are consistent with previ-
ous observations [19].
TaggedPBecause no MSC migration toward the BM was
observed, we hypothesized that, upon entrapment in
the lungs, MSCs secrete soluble factors that in turn
affect the HSC niche and enhance G-CSF-induced
HSPC mobilization. Therefore, MSC culture superna-
tant was administered to recipients that were simulta-
neously mobilized with G-CSF. Coadministration of
MSC culture supernatant and G-CSF enhanced G-CSF-
induced mobilization significantly, whereas administra-
tion of culture supernatant alone did not affect HSPC
migration toward the PB (Figure 3K).
MSC-derived EVs enhance G-CSF induced HSPC
mobilization
TaggedPMSCs have been reported to secrete EVs [20]. To
investigate whether EVs are the supernatant-derived
factor that enhanced G-CSF-induced HSPC mobiliza-
tion, EVs derived from 2£ 106 to 0.2£ 106 MSCs
were administered intravenously for 3 days to recipi-
ents that were simultaneously mobilized with G-CSF.
Co-administration of EVs and G-CSF induced HSPC
mobilization at similar levels as co-injection of MSCs
and G-CSF (Figure 4A). Moreover, administration of
MSC-derived EVs enhanced the cell cycle activity of
LSK cells and downregulated the expression of Cxcl12,
Vcam, and Scf similar to MSC administration
(Figures 4B4E). Previously, it has been shown that
MSCs-derived EVs migrate to the BM [28]. To investi-
gate which BM cells were able to engulf MSC-derived
EVs, BM cells were incubated with PKH26-labeled
EVs for 4 hours and the PKH26+ cells were identified.
Approximately 28% of the CD45+ BM cells were able
to engulf MSC-derived EVs (Figure 4F). Because
>59% of the monocytic cells engulfed EVs
(Figure 4F), we further investigated the phenotype ofTaggedPthe EVPOS monocytic cells. EVPOS monocytic cells
expressed F4/80, CD68, and MERTK at higher levels
than EVNEG monocytic cells. In addition, approxi-
mately 50% of the EVPOS cells expressed the M-CSF
receptor (CD115; Figures 4G4J). This indicates that
macrophages are the main EV-engulfing population in
the BM.
Discussion
TaggedPMSCs are a cellular component of the HSC niche and
play a major role in the maintenance of HSCs in the
BM [1,2]. In addition, in an experimental transplanta-
tion model, coadministration of MSCs and HSPCs has
a beneficial effect on HSC engraftment and hematopoi-
etic recovery [18,19]. This suggests that MSCs are
capable of influencing the HSC niche, leading to
changes that result in altered HSC homeostasis.
TaggedPHere, we show that MSC administration indeed
affects the HSC niche, as well as the BM hematopoi-
etic compartment. Upon MSC administration, HSC
numbers in the BM were decreased, coinciding with
increased HSC cell-cycling activity. Furthermore, MSC
administration induced a decrease in BM macrophage
subsets and concomitant downregulation of Cxcl12,
Vcam, and Scf expression in endosteal cells. Previous
studies have shown that BM macrophages have a regu-
latory role in hematopoiesis and in the HSC niche
[29]. Furthermore, depletion of osteal macrophages and
a downregulation of Cxcl12, Scf, and Ang-1 mRNA is
also observed during G-CSF-induced HSPC mobiliza-
tion [14]. In steady state, macrophages regulate granu-
lopoiesis and induce HSPC egress from the BM
through circadian regulation of Cxcl12 in stromal cells
[30]. The decrease in Cxcl12 expression and HSPC
egress is preceded by the downregulation of liver X
receptor (LXR)target gene downregulation in macro-
phages [30]. Depletion of BM macrophages results in
downregulation of Cxcl12, Vcam, and Scf, increased
HSC proliferation and HSPC mobilization [1315,31].
Together, these previous studies and our data suggest
that HSC-retaining factors in stromal cells are
decreased due to macrophage depletion upon MSC
administration and that increased HSPC cycling and
mobilization may be a direct result of these events.
This effect was specific for MSCs because co-injection
of splenocytes and G-CSF did not enhance HSPC
mobilization.
TaggedP o study the interaction between macrophages and
stromal cells, we performed in vitro experiments in
which RAW264.7 macrophages were co-cultured with
stromal cells. Cellcell contact between RAW264.7
and stromal cells downregulated Cxcl12, Vcam, and Scf
expression in stromal cells, whereas soluble factors
secreted by RAW264.7 macrophages minimally influ-
enced the expression of HSC-supporting genes. This


















































































































G H I J
Figure 4. MSC-derived EVs enhance G-CSF-induced mobilization. (A) MSCs (M) or EVs derived from 2£ 106 to 0.2£ 106 MSCs were admin-
istered intravenously for 3 days to recipients that were simultaneously mobilized with G-CSF (G) or PBS (P) as a control (n = 59 per group).
(B) Cell cycle activity of LSK cells was analyzed using a Ki67/DAPI staining. The frequencies of LSK cells in G0, G1, or S/G2/M phage was
determined and related to PBS controls (n = 46 per group). (CE) Relative RNA expression for (C) CXCL12, (D) VCAM, and (E) SCF was
determined in bone-lining cells after MSC (M) or EV administration for 3 days to recipients that were simultaneously mobilized with G-CSF
(G) or PBS (P) as a control. Gene expression is depicted as relative expression compared with the household gene HPRT (n = 36). Significance
is indicated compared with p (#p = 0.055). (F) PKH26-labeled EV are primarily taken up by monocytes. The percentage of CD45+ BM cells,
granulocytes (Gran), monocytes (Mon), B cells (B), and T cells (T) that have taken up EVs are depicted within the total cell population. (G,H)
Upon EV uptake, monocytes upregulate (G) F4/80, (H) CD68, (I) CD115, and (J) MERTK (data obtained from one experiment). EVneg cells are
depicted as a dotted line, EVpos cells are depicted as filled histograms. Data are depicted as means § standard error of the mean. *p < 0.05,
**p < 0.01, ***p < 0.001.
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1110TaggedPfurther strengthens the evidence for a regulatory role
of macrophages in the stem cell niche and indicates
that cellcell contact between stromal cells and
macrophages is required for the downregulation of
these factors.
TaggedPWhen MSCs were co-administered with G-CSF,
HSPC mobilization was enhanced significantly, indicat-
ing that the HSC niche is altered as a result of MSC
injection. Because these MSCs are trapped in the lungsTaggedPupon administration, it is conceivable that the observed
increased mobilization is induced by a secreted factor.
We considered that EVs secreted by MSCs could play
such a role and therefore we embarked on experiments
in which we coadministered MSCs or MSC-derived
EVs and G-CSF. Indeed, coinjection of EVs and
G-CSF induced HSPC mobilization at similar levels as
MSCs and G-CSF. Coadministration of MSCs or MSC-
derived EVs and G-CSF further downregulated the
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1203TaggedP xpression of Cxcl12, Vcam, and Scf in endosteal cells
compared with injection of either G-CSF or MSCs
alone. Moreover, the events induced by MSC adminis-
tration are independent of the events induced by G-
CSF because sequential administration of MSCs and
G-CSF also enhanced HSPC mobilization.
TaggedPWe show here that, in vitro, MSC-derived EVs are
engulfed by F4/80+MERTK+CD68+ BM-derived macro-
phages. Previously, it has been shown that CD68+ cells
that express the G-CSF-receptor mediate G-CSF-
induced HSPC mobilization [32]. We therefore propose
that, in vivo, MSC-derived EVs negatively affect this
macrophage population, leading to downregulation of
HSC-retaining factors in the niche. This, in turn, indu-
ces a permissive state in the BM that allows for signifi-
cantly enhanced HSPC mobilization when G-CSF is
administered.
TaggedPIn recent years, studies have indicated that MSC-
derived EVs are associated with a variety of hemato-
poietic disorders [3335]. MSC-derived EVs are also
thought to play a supporting role in tissue homeostasis
and to influence responses to injury and infection
[20,36]. EVs secreted by murine or human MSCs, are
able to inhibit radiation-induced apoptosis of the
murine hematopoietic cell line FDC-P1 [28]. In addi-
tion, administration of MSC-derived EVs resulted in
long-term survival in lethally irradiated mice due to a
direct radioprotective effect on HSCs [37].
TaggedPIn conclusion, both MSCs and MSC-derived EVs
alter the stem cell niche and induce a permissive state
in the BM. This state is characterized by macrophage
depletion and downregulation of niche factors, thereby
resulting in enhanced HSPC mobilization upon G-CSF
administration. Further studies will be required to iden-
tify the exact EV component(s) that is responsible for
the effects on the stem cell niche. Identification of this
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TaggedPSupplementary Figure E3Supplementary Figure E1. MSC administration increases HSPC cell cycle activity. Following 3 days of intravenous MSC, femurs were iso-
lated. Using a Ki67/DAPI staining, cell cycle activity of (A) HSC and (B) HPC/MPP was analyzed and related to PBS controls. Data are









































































































Supplementary Figure E2. Effect of MSC administration on the hematopoietic stem cell miroenvironment. Following 3 days of intravenous
MSC or PBS administration (A) osteoprotegerin (OPG) levels were increased in bone marrow extracellular fluid upon MSC administration (n=3
per group). (B) OPG administration does not affect G-CSF-induced mobilization. OPG was administered at 10 mg or 1 mg per day for 3 days.
At the same time points, PBS (P) or G-CSF (G) was administered; n=3-5 per group. (C) M-CSF (n=5-13) levels were determined in bone mar-
row extracellular fluid. Following 3 days of intravenous MSC or PBS administration B cells were significantly decreased in the (D) peripheral







































































































Supplementary Figure E3. (A) Splenocytes (S) were administered intravenously for 3 days at a dose of 200 x103 cells per day to recipients
that were simultaneously mobilized with G-CSF (G; 10 mg per day intraperitoneally for 3 days) or PBS (P) as a control (n= 3 per group). Data
are depicted as mean § SEM. (B) Administration of MSC does not affect elastase levels in the bone marrow. Bone marrow extracellular extracts
were obtained by flushing femurs with 250 ml cold PBS. The cell suspension was centrifuged at 2,300 g for 5 minutes and the supernatant was
stored at -20 ˚C. Elastase activity was determined using the chromogenic substrate N-Succinyl-L-Ala-Ala-Ala-P-nitroanilide (Sigma, Zwijn-
drecht, The Netherlands). Data are depicted as mean § SEM (n=5-6) (C) Csf3R expression was assessed on peripheral blood cells (PB), bone
marrow cells (BM) or MSC and depicted as relative expression compared to the household gene Abl (mean of triplicates are indicated).
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